Anne E. Stanley

Anne E. Stanley

Auto-generated profile, based on publicly available information

Anne E. Stanley

Mass Spectrometry Core, Penn State University College of Medicine, Hershey, PA 17033, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2013 in Journal of Proteome Research
Verified
Journal Article
Closed access
KJKelly A. Jones
Kelly A. Jones
PKPhillip D. Kim
Phillip D. Kim
BPBhavinkumar B. Patel
Bhavinkumar B. Patel
SKSteven G. Kelsen
Steven G. Kelsen
ABAlan Braverman
Alan Braverman
AYAnthony T. Yeung
Anthony T. Yeung

Verified
Journal Article
Open access
PDF file
ISIndu Sinha
Indu Sinha
Rachel FogleRachel Fogle
Rachel Fogle
GGGizem Gulfidan
Gizem Gulfidan
ASAnne E. Stanley
Anne E. Stanley
VWVonn Walter
Vonn Walter
Raghu SinhaRaghu Sinha
Raghu Sinha
Breast cancer is the second leading cause of death for women in the United States, and early detection could offer patients the opportunity to receive early intervention. The current methods of diagnosis rely on mammograms and have relatively high rates of false positivity, causing anxiety in patients. We sought to identify protein markers in saliva and serum for early detection of breast cancer. A rigorous analysis was performed for individual saliva and serum samples from women without breast disease, and women diagnosed with benign or malignant breast disease, using isobaric tags for relative and absolute quantitation (iTRAQ) technique, and employing a random effects model. A total of 591 and 371 proteins were identified in saliva and serum samples from the same individuals, respectively. The differentially expressed proteins were mainly involved in exocytosis, secretion, immune response, neutrophil-mediated immunity and cytokine-mediated signaling pathway. Using a network biology approach, significantly expressed proteins in both biological fluids were evaluated for protein–protein interaction networks and further analyzed for these being potential biomarkers in breast cancer diagnosis and prognosis. Our systems approach illustrates a feasible platform for investigating the responsive proteomic profile in benign and malignant breast disease using saliva and serum from the same women.